Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 2
1982 1
1984 2
1985 5
1986 2
1987 1
1988 1
1989 1
1990 1
1991 2
1992 2
1993 1
1994 2
1995 3
1996 1
1997 2
1998 2
1999 5
2000 2
2001 6
2002 1
2003 5
2004 8
2005 13
2006 11
2007 7
2008 8
2009 5
2010 4
2011 8
2012 6
2013 7
2014 1
2015 4
2016 5
2017 4
2018 6
2019 7
2020 5
2021 4
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Kellokumpu-Lehtinen PL, Harmenberg U, Joensuu T, McDermott R, Hervonen P, Ginman C, Luukkaa M, Nyandoto P, Hemminki A, Nilsson S, McCaffrey J, Asola R, Turpeenniemi-Hujanen T, Laestadius F, Tasmuth T, Sandberg K, Keane M, Lehtinen I, Luukkaala T, Joensuu H; PROSTY study group. Kellokumpu-Lehtinen PL, et al. Among authors: turpeenniemi hujanen t. Lancet Oncol. 2013 Feb;14(2):117-24. doi: 10.1016/S1470-2045(12)70537-5. Epub 2013 Jan 4. Lancet Oncol. 2013. PMID: 23294853 Clinical Trial.
Real-time monitoring of human blood-brain barrier disruption.
Kiviniemi V, Korhonen V, Kortelainen J, Rytky S, Keinänen T, Tuovinen T, Isokangas M, Sonkajärvi E, Siniluoto T, Nikkinen J, Alahuhta S, Tervonen O, Turpeenniemi-Hujanen T, Myllylä T, Kuittinen O, Voipio J. Kiviniemi V, et al. Among authors: turpeenniemi hujanen t. PLoS One. 2017 Mar 20;12(3):e0174072. doi: 10.1371/journal.pone.0174072. eCollection 2017. PLoS One. 2017. PMID: 28319185 Free PMC article.
R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma.
Prusila REI, Haapasaari KM, Marin K, Pollari M, Soini Y, Vornanen M, Karjalainen-Lindsberg ML, Turpeenniemi-Hujanen T, Kuittinen O. Prusila REI, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 2018 Sep;57(9):1265-1267. doi: 10.1080/0284186X.2018.1450522. Epub 2018 Mar 14. Acta Oncol. 2018. PMID: 29537344 No abstract available.
MACOP-B regimen in non-Hodgkin's lymphoma.
Joensuu H, Turpeenniemi-Hujanen T. Joensuu H, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 1992;31(6):657-61. doi: 10.3109/02841869209083849. Acta Oncol. 1992. PMID: 1281651 Clinical Trial.
Incidence of solid cancer in patients with follicular lymphoma.
Sorigue M, Prusila REI, Jauhiainen J, Mercadal S, Postila A, Salmi P, Tanhua T, Tikkanen S, Kakko S, Kuitunen H, Pollari M, Nystrand I, Kuusisto MEL, Vasala K, Jantunen E, Korkeila E, Karihtala P, Sancho JM, Turpeenniemi-Hujanen T, Kuittinen O. Sorigue M, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 2019 Nov;58(11):1564-1569. doi: 10.1080/0284186X.2019.1643918. Epub 2019 Aug 1. Acta Oncol. 2019. PMID: 31368395
157 results